Inherited gene variants may shape CAR-T therapy benefits and toxic side effects

Дата публикации: 24-07-2026 18:00:01

Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma. But in some patients, the treatment can cause serious side effects. New research led by investigators at the Mass General Brigham Cancer Institute, the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute has shown that patients' inherited genetic makeup can influence whether they benefit from CAR-T cell therapy or experience toxicity from the treatment. The results are published in Science Immunology.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Autoantibodies could shape cancer risk, growth and response to immunotherapy	0	9.66	25-07-2026
2	Redesigned lung cancer drug matches tumor control with fewer off-target interactions	0	9.72	24-07-2026
3	Врач Паровичникова: инновационная терапия не заменит трансплантацию костного мозга	0	0	12-04-2025
4	Brain tumor vaccine links mutation targeting to eight-year survival gains	7	8	06-07-2026
5	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
6	Предоперационная иммунотерапия на 10% повышает шансы выживания при раке легких	0	0	02-06-2025
7	UC Irvine study identifies serious infection risks linked to targeted cancer therapies	0	7	02-06-2026
8	New blood test for noncoding RNA significantly improves cancer detection	7	8	31-08-2023
9	Создан подход для оценки эффективности иммунотерапии рака легких	0	0	04-08-2025

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 8.44. Источник: medicalxpress.com.